/Treatment Of Retinitis Pigmentosa And Retinitis Pigmentosa Associated With Usher Syndrome With N-acetylcysteine Amide
Abstract
Provided herein are methods for the treatment of retinitis pigmentosa in a human that comprises administering to the human a therapeutically effective amount of N-acetylcysteine amide (NACA).
Full Text
What is claimed is:
Provided herein are methods for the treatment of retinitis pigmentosa in a human that comprises administering to the human a therapeutically effective amount of N-acetylcysteine amide (NACA).
Timeline
Filed
05/21/2026Published
09/17/2026Granted
Not AvailableIPC Codes(2)
A61K 31/16:Amides, e.g. hydroxamic acids
A61P 27/02:Ophthalmic agents